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Abstract 
 
Purpose:  
 
Conventional teaching regarding palatal injection for the removal of maxillary teeth dictates that 
both a buccal and palatal injection are to be administered. Recently, some authors have 
questioned the necessity of the palatal injection, suggesting that contemporary local anaesthetics 
might diffuse sufficiently across the buccal-palatal cortical bone distance. It has been suggested 
that since the buccal-palatal cortical bone distance increases anteriorly to posteriorly in the 
maxilla, the success of maxillary extractions with buccal injection only, might be related to 
anterior-posterior position of the tooth. 
 
Evidence from clinical trials has only relatively recently become available. Since 2006, fifteen 
clinical trials that examined outcomes of maxillary tooth extractions performed with buccal 
injection of local anaesthetic only, have been published. However, there is limited data available 
regarding the clinical practice of surgeons.  
 
Patients and Methods:  
 
An online survey was sent to 276 full members of the Canadian Association of Oral and 
Maxillofacial Surgeons. Respondents were asked about their use of palatal injection for the 
removal of maxillary teeth under local anaesthesia, including how often they administer a palatal 
injection for maxillary extractions in each region of the maxilla. 
 
Results: 
 
92 responses were received (33%). Most practitioners deliver a palatal injection for every 
maxillary tooth extraction under local anaesthetic. However, there is a significant number who 
do not always administer a palatal injection (i.e. they give it ‘most of the time’, ‘occasionally’ or 
‘never’). This number decreased in a linear fashion anteriorly to posteriorly in the maxilla: 
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incisors: 17/89; canines: 16/88; premolars: 13/88; first and second molars: 10/89; third molars: 
10/88. 
 
Conclusion: 
 
There are a number of surgeons who do not always administer a palatal injection for extraction 
of maxillary teeth under local anaesthetics. The number is greater for anterior compared to 
posterior teeth. 
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Abbreviations: LA: local anaesthetic; OMS: oral and maxillofacial surgeon; SD: standard 
deviation; CI: confidence interval 
 
Introduction 
 
Conventional teaching regarding local anaesthesia for the removal of maxillary teeth dictates that 
both a buccal and palatal injection (block and/or infiltration) are to be administered1. 
Unfortunately, palatal injection is poorly tolerated by patients due to the rich nerve supply of the 
palatal tissues and firm attachment of palatal mucosa to bone2-5. Recently, a number of authors 
have questioned the necessity of administering the palatal injection, suggesting that 
contemporary local anaesthetics might diffuse sufficiently across the buccal-palatal cortical bone 
distance. This distance increases anteriorly to posteriorly in the maxilla; therefore, the success of 
maxillary extractions performed with buccal injection only might be related to anterior-posterior 
position of the tooth6. 
 
In 2007, a survey of Australian and New Zealand OMSs regarding their use of palatal injection 
was conducted by Badcock and McCullough7. The study was limited to extraction of maxillary 
third molars and the authors found that, in line with conventional teaching, palatal injection was 
widely used. However, they identified a small number of practitioners who do not always deliver 
the palatal injection (palatal injection delivered ‘always’: 77/84, ‘most of the time’: 4/84, 
‘occasionally’: 2/84, ‘never’: 1/84). 
 
Fifteen clinical trials (2006-2015) examining outcomes of maxillary tooth extractions performed 
with buccal injection of LA only, have been published, and were the subject of a recent review by 
Badenoch-Jones and Lincoln8. The included trials varied considerably in their designs and the 
authors gave the caveat that the results of each trial should be interpreted within the framework 
of the protocol of the particular study. Nevertheless, it was found that all nine controlled studies 
that assessed pain during the procedure failed to demonstrate a statistically significant difference 
between the test (buccal injection only) and control (buccal and palatal injection) groups. Four 
studies reported results according to region of the maxilla and provided some evidence for better 
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results for anterior compared to posterior teeth, although none of the studies reported a P value 
for comparisons between the groups. The review authors made the point that the relevant 
consideration in clinical practice is the ‘cost’ versus benefit of the intervention (i.e. the pain of 
palatal injection versus the pain that it eliminates during the procedure), whereas, the majority 
of included trials considered only whether they was a benefit from the intervention. 
 
The findings of the 2007 survey7 and the review7, 8, together, raise the possibility that in some 
circumstances, the palatal injection might not be required. The purpose of the current study was 
to examine previously reported estimates for the percentage of practitioners who do not ‘always’ 
deliver a palatal injection, and by way of a similar survey improve on the sample size of the 2007 
survey. We also aimed to expand on the previous research by collecting data for all regions of the 
maxilla in order to analyse for variance in results that might be due to the region. 
 
Methods 
 
Sample Size/Power Calculation 
 
The results of Badcock and McCullough7 for the proportion of practitioners who ‘always’ deliver 
a palatal injection for extraction of maxillary teeth were used to determine the sample size 
required for our study. Although the study by Badcock and McCullough7 was limited to the 
extraction of maxillary third molar teeth, given the similarity expected for results across all 
maxillary teeth, this estimated sample size was used for our study. Our null hypothesis was that 
the proportion of practitioners who ‘always’ deliver a palatal injection for the extraction of 
maxillary teeth, as reported by Badcock and McCullough7 is 0.92. Conversely, our alternative 
hypothesis was that the true population proportion is not 0.92. 
 
According to our calculation, at a power of 80%, a significance level of 5%, and a proportion of 
interest that differed more than 10% from the null proportion of interest (0.92), 89 respondents 
were required for our study. The null proportion was obtained from the study by Badcock and 
McCullough7 in which 77 of the 84 respondents ‘always’ delivered a palatal injection for 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
extraction of maxillary third molars (compared to practitioners who do not ‘always’ deliver the 
palatal injection, i.e. they give it ‘most of the time’, ‘occasionally’ or ‘never’). 
 
We conducted a one-sample proportions test to determine if there was a difference in the 
proportion of respondents that ‘always’ delivered a palatal injection for extraction of maxillary 
third molars in the study by Badcock and McCullough7 and the proportion of respondents that 
‘always’ delivered a palatal injection for extraction of third molars in the present study.  
 
Questionnaire 
 
In constructing our survey, we used the survey by Badcock and McCullough7 (obtained from the 
authors) as a reference. Respondents were asked how often they administered a palatal injection 
for permanent maxillary extractions under local anaesthetic in each region of the maxilla, 
grouped as: incisors (central and lateral), canines, premolars, first and second molars, and third 
molars. For this question, the same format as that used by Badcock and McCullough was 
maintained so that the results of the present study could be pooled with those obtained by 
Badcock and McCullough (for third molars). For the remainder of the survey, we used similar 
questions to those of Badcock and McCullough, although we sought more detailed information 
from respondents for some questions..Respondents were also able to provide general comments 
at the conclusion of the survey.   
 
Our online survey was distributed via email link by The Canadian Association of Oral and 
Maxillofacial Surgeons (CAOMS) to all active full members (276), followed by a reminder to non-
responders 3 weeks later. Members were advised that participation in the study was voluntary 
and that their response could not be identified.   
 
Approval for the study was gained from The University of Queensland Dental Sciences Research 
Ethics Committee. 
 
Results 
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Ninety-two members responded to the survey (33%), although some respondents did not 
complete all of the survey components. The respondents had practised as qualified OMSs in 
Canada or overseas for an average of 19.3 (SD: 11.5) years full time equivalent.  
 
The responses are shown in Tables 1-3.  
 
Table 1 
 
A one-sample proportions test indicated no significant difference (p=0.52) between the 
proportion of respondents that ‘always’ delivered a palatal injection for third molars in the study 
by Badcock and McCullough7 (77/84, 0.92) and the proportion of respondents that ‘always’ 
delivered a palatal injection for third molars in the present study (79/88, 0.90 (95% CI: 0.83-
0.96). 
 
With the addition of intravenous sedation, 16% (15/92) of practitioners administer the palatal 
injection ‘more commonly’, 12% (11/92) ‘less commonly’, while for 72% (66/92) there is no 
difference. 
 
Table 2 
 
Of the respondents who were influenced by patient anxiety level in the delivery of the palatal 
injection, 69% (11/16) were ‘more likely’ to administer the injection for an anxious patient, 
while 31% (5/16) were ‘less likely’ to administer the injection for an anxious patient.  
 
None of the respondents indicated that there were any additional factors, not included in the 
survey, which influence whether or not they administer a palatal injection (aside from tooth 
eruption status which we consider to fall under our category, pre-operative assessment: 
tooth/alveolar anatomy). One respondent commented that they administer a high posterior 
superior alveolar nerve block and that this usually achieves palatal anaesthesia.  
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Table 3 
 
The gauge of needles used by respondents to reduce the discomfort of palatal injection ranged 
from 25 to 33 (median: 30).  
 
Other techniques employed to reduce the discomfort of palatal injection that were not included 
in the survey but which are utilized by respondents were: 
-nitrous oxide (1 respondent) 
-intraligamentary and/or intrapapillary injection prior to palatal injection (2 
respondents) 
 
One respondent provided the comment that the techniques he/she uses to reduce the discomfort 
of palatal injection are not used for every patient. It is likely that this is the case for other 
respondents as well. 
 
Discussion and Conclusion 
 
Discussion of Results 
 
In order to maximize the response rate, the authors aimed to keep the survey concise, and 
therefore collected only the data most relevant to answering the research question. As such, 
there was no aim to assess the independent effect of covariates such as geographical location, 
age, and gender, etc. Further, as the survey was completed on the basis of self-report and only 
given once, it was not possible to evaluate reliability metrics such as intra-rater and inter-rater 
reliability.  
 
Limitations of the study include the possibility of non-response bias (difference in the estimate 
provided by the respondents vs the population estimate). No comparison between responders 
and non-responders was possible, as the research team was unable to collect covariate 
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information from the non-responders. We note that surveys of professionals (especially health 
professionals) generally have low response rates, with rates less than 33% not uncommon. 
Further, a low response rate does not necessarily impart substantial bias(es), as the survey was 
not of the general population but rather of a specific target population that is more homogenous.9 
 
There is also the possibility of response bias, which occurs when respondents do not provide 
accurate responses. The particular type of survey and the population of respondents do not make 
this survey vulnerable to this type of bias, and further, we avoided yes/no answers, instead using 
the following options: ‘always’, ‘most of the time’, ‘occasionally’ and ‘never’.  
 
It is the view of this research team that the utilized one-page questionnaire has face validity (i.e. 
according to the responders, the survey measures what it intends to) and content validity (i.e. 
that the survey actually measures what it intends to). 
 
The number of practitioners who did not ‘always’ administer a palatal injection for the removal 
of maxillary teeth (i.e. they give it ‘most of the time’, ‘occasionally’ or ‘never’) decreased in a 
broadly linear fashion anteriorly to posteriorly in the maxilla (incisors: 17/89; canines: 16/88; 
premolars: 13/88; first and second molars: 10/89; third molars: 10/88). It may be that a greater 
number of practitioners ‘always’ administer the palatal injection further posteriorly in the 
maxilla because of the increased buccal-palatal cortical bone distance, or because of clinical 
experience reflecting this fact. 
 
It is interesting to note the inconsistency in use of palatal injection for patients whom the 
practitioner judges to be anxious. Presumably, the practitioners who are ‘more likely ‘ to 
administer the palatal injection for these patients do so to reduce pain during the procedure, 
while those practitioners who are ‘less likely’ to administer the palatal injection for these 
patients do so to avoid the pain of injection. At the crux of this inconsistency appears to be 
uncertainty over the relative cost (i.e. pain of palatal injection) and benefit (i.e. pain that it 
eliminates during the procedure) of the intervention (i.e. palatal injection). The former group of 
practitioners must believe that the benefit outweighs the cost, while the latter group must 
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believe that the cost outweighs the benefit. As mentioned earlier, the authors of the 
aforementioned systematic review8 highlighted that the majority of clinical trails on the topic 
addressed only the benefit of the intervention, and not the cost; therefore, available evidence for 
cost versus benefit is sparse (the two trials where cost versus benefit was reported or could be 
calculated found that cost outweighed the benefit). 
 
The results suggest that the factors which influence whether or not a palatal injection is 
administered by a surgeon vary according to the individual practitioner (only 14-40% are 
influenced by each factor). By contrast, there is greater consistency among practitioners in the 
techniques employed to reduce the discomfort of palatal injection (either uncommonly used (0-
3%) or relatively commonly used (62-72%)).   
 
Notwithstanding the nine-year difference in the dates of data collection (and the possibility of 
changing practice with time), the concordance of the results for third molars reported by 
Badcock and McCullough7, and in the present study (p=0.52), indicates similar practice in 
Australia/New Zealand and Canada. This is likely to be the case for other western countries as 
well. 
 
While the results of this survey provide some additional evidence regarding the use of palatal 
injection for maxillary tooth extractions, data are still limited. Building on the current evidence 
with appropriately designed and executed trials will be necessary. Points to be addressed include 
the cost of the intervention, and trends in results according to region of the maxilla (to date, no 
trial has presented results according to region of the maxilla appropriately, i.e. with P values 
comparing groups). 
 
Ideal Study Design 
 
The following are our suggestions for further trials to address the identified gaps in knowledge: 
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-Double blinded randomised controlled trials with large cohorts using saline palatal injection as 
the control. 
-Inclusion of all maxillary teeth, grouped as: incisors (central and lateral), canine, premolars, first 
and second molars, third molars. Results of groups compared with appropriate statistics.  
-Lignocaine hydrochloride or articaine hydrochloride standard dose for both buccal injection/s 
and palatal injection/s.  
-Procedure 5 minutes after delivery of LA. For cases of failed initial anaesthesia, supplemental 
buccal injection, and if unsuccessful after 5 minutes, supplemental palatal injection. 
-Unsuccessful anaesthesia determined by pain during the procedure, rather than by probing of 
the mucosa (the former directly addresses the research question). 
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Table 1. Number (%) of respondents: how often a palatal injection is administered for maxillary 
tooth extractions under LA according to region of the maxilla.  
 
Region of 
Maxilla 
Always Most of the 
time 
Occasionally Never  Total 
Maxillary 
incisors (central 
and lateral 
incisors) 
73 (82) 12 (13) 2 (2) 2 (2) 89 
Maxillary 
canines 
74 (84) 12 (14) 1 (1) 1 (1) 88  
Maxillary 
premolars 
76 (86) 10 (11) 1 (1) 1 (1) 88 
Maxillary first 
and second 
molars 
80 (90) 7 (8) 1 (1) 1 (1) 89 
Maxillary third 
molars 
79 (90) 3 (3) 5 (6) 1 (1) 88 
Results of Badcock and McCullough7 
Maxillary third 
molars 
77 (92) 4 (5) 2 (2) 1 (1) 84 
Total: present study and Badcock and McCullough7 
Maxillary third 
molars 
156 (91) 7 (4) 7 (4) 2 (1) 172 
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Table 2. Number (%) of respondents: factors which influence whether or not a palatal injection is 
administered. 
 
 Yes No Total 
Indication for tooth extraction (such as 
caries, apical lesion, pericoronitis, 
orthodontic treatment plan, prophylactic 
extraction) 
 
17 (25) 51 (75) 68 
Pre-operative assessment: tooth/alveolar 
anatomy 
 
15 (21) 55 (79) 70 
Pre-operative assessment: likelihood of 
simple versus surgical extraction 
 
13 (19) 57 (81) 70 
Patient anxiety level 
 
16 (23) 54 (77) 70 
Pain during extraction 
 
28 (40) 42 (60) 70 
Type of LA used for buccal (vestibular) 
infiltration or buccal nerve block (eg 
lignocaine, articaine, mepivacaine) 
 
10 (14) 59 (86) 69 
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Table 3. Number (%) of respondents: techniques employed to reduce the discomfort of palatal 
injection 
 
 Yes No Total 
Pressure applied to the area of 
needle penetration 
 
63 (72) 25 (28) 88 
Conventional topical 
anaesthetics 
 
63 (72) 24 (28) 87 
Eutectic mixture of local 
anaesthetic (EMLA) cream 
 
2 (3) 72 (97) 74 
Topical cooling of the palate (eg 
topical ice) 
 
1 (1) 74 (99) 75 
Fine gauge needle 
 
52 (62) 32 (38) 84 
Computerised delivery system 
 
1 (1) 75 (99) 76 
Transcutaneous electronic 
nerve stimulation (TENS) 
 
0 (0) 75 (100) 75 
 
 
 
